SC
IVVD icon

Stempoint Capital’s Invivyd IVVD Stock Holding History

Stempoint Capital’s Portfolio IVVD Stock Details IVVD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,874,546
Closed -$2.44M – 98
2026
Q1 		$2.44M Buy
1,874,546
+884,724
+89% +$1.62M 0.47% 50
2025
Q4 		$2.44M Buy
989,822
+711,214
+255% +$1.48M 0.42% 55
2025
Q3 		$306K Buy
+278,608
New +$247K 0.06% 78

Other funds holding IVVD

JT
Jupiter Topco New York $245B AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Stempoint Capital's IVVD Position: Q2 2026 in Review

Stempoint Capital sold out of Invivyd (IVVD) in Q2 2026, closing a stake of 1,874,546 shares — an estimated $2.44M sold.

Stempoint Capital first reported a position in IVVD in Q3 2025 and held it in 3 quarters. The position peaked at $2.44M in Q4 2025. 125 funds tracked by Wall St. Rank hold IVVD as of Q2 2026.

  • Stempoint Capital reported no remaining Invivyd position as of Q2 2026 after selling out during the quarter.
  • Stempoint Capital sold 1,874,546 Invivyd shares in Q2 2026, an estimated $2.44M.
  • Stempoint Capital first reported a position in Invivyd in Q3 2025 and held it in 3 quarters.
  • Stempoint Capital's Invivyd position peaked at $2.44M in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Invivyd as of Q2 2026.

Based on Stempoint Capital's 13F filing for Q2 2026, filed 14 Aug 2026.